Vitamin D high doses supplementation could represent a promising alternative to prevent or treat COVID-19 infection

[1]  R. Kenny,et al.  Editorial: low population mortality from COVID‐19 in countries south of latitude 35 degrees North supports vitamin D as a factor determining severity , 2020, Alimentary pharmacology & therapeutics.

[2]  Qingbo Xu,et al.  Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19 , 2020, Circulation research.

[3]  C. Yancy,et al.  COVID-19 and African Americans. , 2020, JAMA.

[4]  M. Alipio.  Vitamin D Supplementation Could Possibly Improve Clinical Outcomes of Patients Infected with Coronavirus-2019 (COVID-2019) , 2020 .

[5]  W. Grant,et al.  Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths , 2020, Nutrients.

[6]  P. Calmarza,et al.  Association between preoperative levels of 25-hydroxyvitamin D and hospital-acquired infections after hepatobiliary surgery: A prospective study in a third-level hospital , 2020, PloS one.

[7]  O. Pfister,et al.  SARS-CoV2: should inhibitors of the renin–angiotensin system be withdrawn in patients with COVID-19? , 2020, European heart journal.

[8]  W. Grant,et al.  Vitamin D Supplementation Could Prevent and Treat Influenza, Coronavirus, and Pneumonia Infections , 2020 .

[9]  G. Herrler,et al.  SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor , 2020, Cell.

[10]  D. Gurwitz.  Angiotensin receptor blockers as tentative SARS‐CoV‐2 therapeutics , 2020, Drug development research.

[11]  K. Yuen,et al.  Clinical Characteristics of Coronavirus Disease 2019 in China , 2020, The New England journal of medicine.

[12]  Zunyou Wu,et al.  Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. , 2020, JAMA.

[13]  G. Su,et al.  [Inhibitors of RAS Might Be a Good Choice for the Therapy of COVID-19 Pneumonia]. , 2020, Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases.

[14]  Y. Hu,et al.  Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China , 2020, The Lancet.

[15]  M. Holick,et al.  The Effect of Various Doses of Oral Vitamin D3 Supplementation on Gut Microbiota in Healthy Adults: A Randomized, Double-blinded, Dose-response Study , 2019, AntiCancer Research.

[16]  F. Holsboer,et al.  SKP2 attenuates autophagy through Beclin1-ubiquitination and its inhibition reduces MERS-Coronavirus infection , 2019, Nature Communications.

[17]  S. Urcuqui-Inchima,et al.  Effect of high doses of vitamin D supplementation on dengue virus replication, Toll-like receptor expression, and cytokine profiles on dendritic cells , 2019, Molecular and Cellular Biochemistry.

[18]  M. Holick,et al.  Disassociation of Vitamin D’s Calcemic Activity and Non-calcemic Genomic Activity and Individual Responsiveness: A Randomized Controlled Double-Blind Clinical Trial , 2019, Scientific Reports.

[19]  Saharnaz Nedjat,et al.  Effect of single‐dose injection of vitamin D on immune cytokines in ulcerative colitis patients: a randomized placebo‐controlled trial , 2019, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[20]  P. Thomas,et al.  Influenza virus-related critical illness: pathophysiology and epidemiology , 2019, Critical Care.

[21]  J. Ware,et al.  Vitamin D Supplementation and Prevention of Type 2 Diabetes. , 2019, The New England journal of medicine.

[22]  D. Lehrer,et al.  Daily oral dosing of vitamin D3 using 5000 TO 50,000 international units a day in long-term hospitalized patients: Insights from a seven year experience , 2019, The Journal of Steroid Biochemistry and Molecular Biology.

[23]  David A. Jolliffe,et al.  Vitamin D to prevent exacerbations of COPD: systematic review and meta-analysis of individual participant data from randomised controlled trials , 2019, Thorax.

[24]  F. Shokri,et al.  The interplay between vitamin D and viral infections , 2019, Reviews in medical virology.

[25]  J. Manson,et al.  Vitamin D Supplements and Prevention of Cancer and Cardiovascular Disease , 2019, The New England journal of medicine.

[26]  H. Tajiri,et al.  Randomized Trial of Vitamin D Supplementation to Prevent Seasonal Influenza and Upper Respiratory Infection in Patients With Inflammatory Bowel Disease , 2019, Inflammatory bowel diseases.

[27]  R. Hampl,et al.  Impaired vitamin D sensitivity. , 2018, Physiological research.

[28]  Beata M. Gruber-Bzura.  Vitamin D and Influenza—Prevention or Therapy? , 2018, International journal of molecular sciences.

[29]  P. Pfeffer,et al.  Effects of vitamin D on inflammatory and oxidative stress responses of human bronchial epithelial cells exposed to particulate matter , 2018, bioRxiv.

[30]  S. Urcuqui-Inchima,et al.  High-dose of vitamin D supplement is associated with reduced susceptibility of monocyte-derived macrophages to dengue virus infection and pro-inflammatory cytokine production: An exploratory study. , 2018, Clinica chimica acta; international journal of clinical chemistry.

[31]  Y. Shang,et al.  Vitamin D reduces inflammatory response in asthmatic mice through HMGB1/TLR4/NF-κB signaling pathway , 2017, Molecular medicine reports.

[32]  X. Li,et al.  The vasoprotective axes of the renin‐angiotensin system: Physiological relevance and therapeutic implications in cardiovascular, hypertensive and kidney diseases , 2017, Pharmacological research.

[33]  Q. Luo,et al.  Vitamin D alleviates lipopolysaccharide-induced acute lung injury via regulation of the renin-angiotensin system , 2017, Molecular medicine reports.

[34]  C. Akdis,et al.  Respiratory syncytial virus infection influences tight junction integrity , 2017, Clinical and experimental immunology.

[35]  Mahmood A. Al-Azzawi,et al.  Evaluation of Vitamin D, Vitamin D Binding Protein Gene Polymorphism with Oxidant – Antioxidant Profiles in Chronic Obstructive Pulmonary Disease , 2017, Journal of medical biochemistry.

[36]  F. Colotta,et al.  Modulation of inflammatory and immune responses by vitamin D. , 2017, Journal of autoimmunity.

[37]  V. Gudnason,et al.  Non-skeletal health effects of vitamin D supplementation: A systematic review on findings from meta-analyses summarizing trial data , 2017, PloS one.

[38]  M. Flodström-Tullberg,et al.  Vitamin D treatment modulates immune activation in cystic fibrosis , 2017, Clinical and experimental immunology.

[39]  Jianhua Fu,et al.  Vitamin D attenuates hyperoxia-induced lung injury through downregulation of Toll-like receptor 4 , 2017, International journal of molecular medicine.

[40]  Rehana A. Salam,et al.  Vitamin D supplementation for preventing infections in children under five years of age , 2016, The Cochrane database of systematic reviews.

[41]  M. Loeb,et al.  Effect of Vitamin D3 Supplementation on Respiratory Tract Infections in Healthy Individuals: A Systematic Review and Meta-Analysis of Randomized Controlled Trials , 2016, PloS one.

[42]  De-xiang Xu,et al.  Calcitriol inhibits bleomycin-induced early pulmonary inflammatory response and epithelial-mesenchymal transition in mice. , 2016, Toxicology letters.

[43]  K. Samitas,et al.  Vitamin-D in the Immune System: Genomic and Non-Genomic Actions. , 2015, Mini reviews in medicinal chemistry.

[44]  Zhongrong Yang,et al.  Vitamin D supplementation for the prevention of childhood acute respiratory infections: a systematic review of randomised controlled trials , 2015, British Journal of Nutrition.

[45]  A. Martineau,et al.  Modulation of the Immune Response to Respiratory Viruses by Vitamin D , 2015, Nutrients.

[46]  E. Giovannucci,et al.  The Importance of Body Weight for the Dose Response Relationship of Oral Vitamin D Supplementation and Serum 25-Hydroxyvitamin D in Healthy Volunteers , 2014, PloS one.

[47]  I. Reid,et al.  The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes: a trial sequential meta-analysis. , 2014, The lancet. Diabetes & endocrinology.

[48]  J. Alvarez,et al.  Large, single-dose, oral vitamin D supplementation in adult populations: a systematic review. , 2014, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[49]  C. Camargo,et al.  Association between preoperative 25-hydroxyvitamin D level and hospital-acquired infections following Roux-en-Y gastric bypass surgery. , 2014, JAMA surgery.

[50]  Meenu Singh,et al.  Vitamin D Supplementation for the Treatment of Acute Childhood Pneumonia: A Systematic Review , 2013, ISRN pediatrics.

[51]  Songming Huang,et al.  Vitamin D supplementation and risk of respiratory tract infections: A meta-analysis of randomized controlled trials , 2013, Scandinavian journal of infectious diseases.

[52]  David A. Jolliffe,et al.  Vitamin D in the prevention of acute respiratory infection: Systematic review of clinical studies , 2013, The Journal of Steroid Biochemistry and Molecular Biology.

[53]  J. Lindh,et al.  Vitamin D and Respiratory Tract Infections: A Systematic Review and Meta-Analysis of Randomized Controlled Trials , 2013, PloS one.

[54]  F. Inserra,et al.  The world pandemic of vitamin D deficiency could possibly be explained by cellular inflammatory response activity induced by the renin-angiotensin system. , 2013, American journal of physiology. Cell physiology.

[55]  I. Rahman,et al.  Pharmacological and dietary antioxidant therapies for chronic obstructive pulmonary disease. , 2013, Current medicinal chemistry.

[56]  S. Mastaglia,et al.  Diagnóstico, prevención y tratamiento de la hipovitaminosis D , 2013 .

[57]  W. Tian,et al.  [Expression of RANTES in the lung tissue of asthmatic rats, and the intervention effect of vitamin D on RANTES expression]. , 2012, Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics.

[58]  D. Saxena,et al.  Vitamin D for prevention of respiratory tract infections: A systematic review and meta-analysis , 2012, Journal of pharmacology & pharmacotherapeutics.

[59]  M. Fornés,et al.  Role of mitochondria in paricalcitol-mediated cytoprotection during obstructive nephropathy. , 2012, American journal of physiology. Renal physiology.

[60]  D. Samaras,et al.  Aging Adults and Seasonal Influenza: Does the Vitamin D Status (H)Arm the Body? , 2011, Journal of aging research.

[61]  K. Ueno,et al.  1α,25-Dihydroxyvitamin D3 inhibits neutrophil recruitment in hamster model of acute lung injury , 2011, Steroids.

[62]  W. Grant.  An estimate of the global reduction in mortality rates through doubling vitamin D levels , 2011, European Journal of Clinical Nutrition.

[63]  C. Mathieu,et al.  Vitamin D in autoimmune, infectious and allergic diseases: a vital player? , 2011, Best practice & research. Clinical endocrinology & metabolism.

[64]  I. Chiodini,et al.  Effect of a single oral dose of 600,000 IU of cholecalciferol on serum calciotropic hormones in young subjects with vitamin D deficiency: a prospective intervention study. , 2010, The Journal of clinical endocrinology and metabolism.

[65]  T. Casale,et al.  The role of vitamin D in asthma. , 2010, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[66]  P. DePetrillo,et al.  Serum 25-Hydroxyvitamin D and the Incidence of Acute Viral Respiratory Tract Infections in Healthy Adults , 2010, PloS one.

[67]  M. Urashima,et al.  Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren. , 2010, The American journal of clinical nutrition.

[68]  G. Dranitsaris,et al.  A phase 2 trial exploring the effects of high‐dose (10,000 IU/day) vitamin D3 in breast cancer patients with bone metastases , 2010, Cancer.

[69]  G. Mazzucco,et al.  Mitochondrial Localization of Vitamin D Receptor in Human Platelets and Differentiated Megakaryocytes , 2010, PloS one.

[70]  E. Giovannucci,et al.  The possible roles of solar ultraviolet-B radiation and vitamin D in reducing case-fatality rates from the 1918–1919 influenza pandemic in the United States , 2009, Dermato-endocrinology.

[71]  T. Ziegler,et al.  Vitamin D for treatment and prevention of infectious diseases: a systematic review of randomized controlled trials. , 2009, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[72]  C. Camargo,et al.  Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey. , 2009, Archives of internal medicine.

[73]  J. Mora,et al.  Vitamin effects on the immune system: vitamins A and D take centre stage , 2008, Nature Reviews Immunology.

[74]  P. Henricks,et al.  1α,25-Dihydroxyvitamin D3 Potentiates the Beneficial Effects of Allergen Immunotherapy in a Mouse Model of Allergic Asthma: Role for IL-10 and TGF-β1 , 2008, The Journal of Immunology.

[75]  Glenville Jones.  PHOSPHORUS METABOLISM AND MANAGEMENT IN CHRONIC KIDNEY DISEASE: Expanding Role for Vitamin D in Chronic Kidney Disease: Importance of Blood 25‐OH‐D Levels and Extra‐Renal 1α‐Hydroxylase in the Classical and Nonclassical Actions of 1α,25‐Dihydroxyvitamin D3 , 2007 .

[76]  L. Bodnar,et al.  High prevalence of vitamin D insufficiency in black and white pregnant women residing in the northern United States and their neonates. , 2007, The Journal of nutrition.

[77]  S. Madronich,et al.  Epidemic influenza and vitamin D , 2006, Epidemiology and Infection.

[78]  M. Dallman,et al.  Reversing the defective induction of IL-10-secreting regulatory T cells in glucocorticoid-resistant asthma patients. , 2005, The Journal of clinical investigation.

[79]  Michel Theron,et al.  A probable role for IFN-γ in the development of a lung immunopathology in SARS , 2005, Cytokine.

[80]  Arthur S Slutsky,et al.  Angiotensin-converting enzyme 2 protects from severe acute lung failure , 2005, Nature.

[81]  A. Harmelin,et al.  The anti‐inflammatory effects of 1,25‐dihydroxyvitamin D3 on Th2 cells in vivo are due in part to the control of integrin‐mediated T lymphocyte homing , 2004, European journal of immunology.

[82]  John L. Sullivan,et al.  Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus , 2003, Nature.

[83]  J. Schröder,et al.  Human beta-defensin-2. , 1999, The international journal of biochemistry & cell biology.

[84]  M. Thomasset,et al.  Control of nuclear transcription of vitamin D‐dependent genes by vitamin D , 1997, Current opinion in nephrology and hypertension.

[85]  R. Wernyj,et al.  Genomic mechanisms involved in the pleiotropic actions of 1,25-dihydroxyvitamin D3. , 1996, The Biochemical journal.

[86]  J. Adams,et al.  1,25-Dihydroxyvitamin D3 suppresses human T helper/inducer lymphocyte activity in vitro. , 1985, Journal of immunology.

[87]  J. Luban.  SARS-CoV-2 , 2020 .

[88]  Rose Anne Kenny,et al.  Irish Longitudinal Study on Ageing (TILDA) , 2015 .

[89]  Y. Shang,et al.  Role of 1,25-dihydroxyvitamin D3 in the treatment of asthma. , 2014, European review for medical and pharmacological sciences.

[90]  G. Schwalfenberg,et al.  A review of the critical role of vitamin D in the functioning of the immune system and the clinical implications of vitamin D deficiency. , 2011, Molecular nutrition & food research.

[91]  RESEARCH ARTICLE Biomarkers in Lung Diseases: From Pathogenesis to Prediction to New Therapies Attenuation of pulmonary ACE2 activity impairs inactivation of des-Arg 9 bradykinin/BKB1R axis and facilitates LPS-induced neutrophil infiltration , 2022 .